SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 4, 2008, Pages 609-624

Impurity profile study of capecitabine

Author keywords

Capecitabine; Impurities; Reversed phase HPLC; Synthetic intermediates

Indexed keywords

EID: 70450265557 PISSN: 12332356 EISSN: 20835736 Source Type: Journal
DOI: 10.1556/AChrom.20.2008.4.7 Document Type: Article

Times cited : (6)

References (17)

1
- 0032820506
- A.A. Adjei, Br. J. Clin. Pharmacol., 48, 265-277 (1999)
- (1999) Br. J. Clin. Pharmacol. , vol.48 , pp. 265-277
- Adjei, A.A.¹

2
- 3242885517
- L. Zufia, A. Aldaz, and J. Giraldez, J. Chromatogr. B, 809, 51-58 (2004)
- (2004) J. Chromatogr. B , vol.809 , pp. 51-58
- Zufia, L.¹ Aldaz, A.² Giraldez, J.³

3
- 0033512792
- R. Diasio, Drugs, 58, Supplement 3, 119-126 (1999)
- (1999) Drugs , vol.58 , Issue.SUPPL 3 , pp. 119-126
- Diasio, R.¹

4
- 2342624007
- F.G.A. Jansman, M.J. Postma, D.V. Hartskamp, P.H.B. Willemse, and J.R.B.J. Brouwers, Clin. Ther., 26, 579-589 (2004)
- (2004) Clin. Ther. , vol.26 , pp. 579-589
- Jansman, F.G.A.¹ Postma, M.J.² Hartskamp, D.V.³ Willemse, P.H.B.⁴ Brouwers, J.R.B.J.⁵

5
- 14444280873
- B. Reigner, J. Verweij, L. Dirix, J. Cassidy, C. Twelves, D. Allman, E. Weidekamm, B. Roos, L. Banken, M. Utoh, and B. Osterwalder, Clin. Cancer Res., 4, 941-948 (1998)
- (1998) Clin. Cancer Res. , vol.4 , pp. 941-948
- Reigner, B.¹ Verweij, J.² Dirix, L.³ Cassidy, J.⁴ Twelves, C.⁵ Allman, D.⁶ Weidekamm, E.⁷ Roos, B.⁸ Banken, L.⁹ Utoh, M.¹⁰ Osterwalder, B.¹¹

6
- 9144238357
- W. Scheithauer, J. McKendrick, S. Begbie, M. Borner, W.I. Burns, H.A. Burris, J. Cassidy, D. Jodrell, P. Koralewski, E.L. Levine, N. Marschner, J. Maroun, P. Garcia-Alfonso, J. Tujakowski, G. Van Hazel, A. Wong, J. Zaluski, and C. Twelves, Ann. Oncol., 14, 1735-1743 (2003)
- (2003) Ann. Oncol. , vol.14 , pp. 1735-1743
- Scheithauer, W.¹ McKendrick, J.² Begbie, S.³ Borner, M.⁴ Burns, W.I.⁵ Burris, H.A.⁶ Cassidy, J.⁷ Jodrell, D.⁸ Koralewski, P.⁹ Levine, E.L.¹⁰ Marschner, N.¹¹ Maroun, J.¹² Garcia-Alfonso, P.¹³ Tujakowski, J.¹⁴ Van Hazel, G.¹⁵ Wong, A.¹⁶ Zaluski, J.¹⁷ Twelves, C.¹⁸

7
- 0037837645
- W. Scheithauer, G.V. Kornek, M. Raderer, B. Schull, K. Schmid, E. Kovats, B. Schneeweiss, F. Lang, A. Lenauer, and D. Depisch, J. Clin. Oncol., 21, 1307-1312 (2003)
- (2003) J. Clin. Oncol. , vol.21 , pp. 1307-1312
- Scheithauer, W.¹ Kornek, G.V.² Raderer, M.³ Schull, B.⁴ Schmid, K.⁵ Kovats, E.⁶ Schneeweiss, B.⁷ Lang, F.⁸ Lenauer, A.⁹ Depisch, D.¹⁰

8
- 26844581328
- S.M. Guichard, I. Mayer, and D.I. Jodrell, J. Chromatogr. B, 826, 232-237 (2005)
- (2005) J. Chromatogr. B , vol.826 , pp. 232-237
- Guichard, S.M.¹ Mayer, I.² Jodrell, D.I.³

9
- 33845468767
- M.R. Dhananjeyan, J. Liu, C. Bykowski, J.A. Trendel, J.G. Sarver, H. Ando, and P.W. Erhardt, J. Chromatogr. A, 1138, 101-108 (2007)
- (2007) J. Chromatogr. A , vol.1138 , pp. 101-108
- Dhananjeyan, M.R.¹ Liu, J.² Bykowski, C.³ Trendel, J.A.⁴ Sarver, J.G.⁵ Ando, H.⁶ Erhardt, P.W.⁷

10
- 85153195475
- X.U. Yan and J.L. Grem, J. Chromatogr. B, 783, 273-285 (2003)
- (2003) J. Chromatogr. B , vol.783 , pp. 273-285
- Yan, X.U.¹ Grem, J.L.²

11
- 33745142166
- A. Salvador, L. Millerioux, and A. Renou, Chromatographia 63, 609-615 (2006)
- (2006) Chromatographia , vol.63 , pp. 609-615
- Salvador, A.¹ Millerioux, L.² Renou, A.³

12
- 0037969390
- F. Desmoulin, V. Gilard, R. Martino, and M. Malet-Martino, J. Chromatogr. B, 792, 323-332 (2003)
- (2003) J. Chromatogr. B , vol.792 , pp. 323-332
- Desmoulin, F.¹ Gilard, V.² Martino, R.³ Malet-Martino, M.⁴

13
- 23644433986
- R. Martino, V. Gilard, F. Desmoulin, and M. Malet-Martino, J. Pharm. Biomed. Anal., 38, 871-891 (2005)
- (2005) J. Pharm. Biomed. Anal. , vol.38 , pp. 871-891
- Martino, R.¹ Gilard, V.² Desmoulin, F.³ Malet-Martino, M.⁴

14
- 33644688432
- M. Malet-Martino, V. Gilard, F. Desmoulin, and R. Martino, Clin. Chim. Acta, 366, 61-73 (2006)
- (2006) Clin. Chim. Acta , vol.366 , pp. 61-73
- Malet-Martino, M.¹ Gilard, V.² Desmoulin, F.³ Martino, R.⁴

15
- 0000296605
- Draft Revised Guidance on Impurities in New Drug Substances. Q3A(R). Federal Register
- International Conference on Harmonization, Draft Revised Guidance on Impurities in New Drug Substances. Q3A(R). Federal Register, 65, 45085-45090 (2000)
- (2000) International Conference on Harmonization , vol.65 , pp. 45085-45090

16
- 0003228192
- IFPMA, Switzerland, Federal Register
- ICH Draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology, IFPMA, Switzerland, Federal Register, 60, 11260 (1995)
- (1995) ICH Draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology , vol.60 , pp. 11260

17
- 85153307669
- M. Arasaki, H. Ishitsuka, I. Kuruma, M. Miwa, C. Murasaki, N. Shimma, and I. Umeda, United States Patent 5472949, Dec. 5, 1995
- M. Arasaki, H. Ishitsuka, I. Kuruma, M. Miwa, C. Murasaki, N. Shimma, and I. Umeda, United States Patent 5472949, Dec. 5, 1995

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.